Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile

dc.contributor.authorPalacios, Alfredo
dc.contributor.authorCairoli, Federico Rodriguez
dc.contributor.authorBalan, Dario
dc.contributor.authorBalmaceda, Carlos
dc.contributor.authorAugustovski, Federico
dc.contributor.authorPichon-Riviere, Andres
dc.contributor.authorBardach, Ariel
dc.date.accessioned2025-01-20T20:18:34Z
dc.date.available2025-01-20T20:18:34Z
dc.date.issued2023
dc.description.abstractObjectiveTo estimate the budget impact of covering the FreeStyle Libre Flash Continuous Glucose Monitoring System (FSL) for type 1 Diabetes Mellitus patients (T1DM), compared to self-monitoring of blood glucose (SMBG), from the perspective of public and private third-party payers in Chile.MethodsA budget impact model was developed to estimate the cost difference between SMBG and FSL over five years. Two FSL coverage schemes were assessed. Input parameters were retrieved from the literature review and complemented by expert opinion. Healthcare costs were estimated by a micro-costing approach and reported in USD.ResultsFor a public sector third-party payer, incorporating FSL implied a cost increase up to USD 0.013 per member per month (PMPM) for the fifth year under the broad coverage scheme and a net saving of 0.0001 PMPM (all years) under the restricted coverage scheme. From a private sector third-party payer, incorporating FSL implied savings up to USD 0.028 PMPM (fifth year) for the broad coverage scheme and up to USD 0.012 PMPM (fifth year) for the restricted scheme.ConclusionIncorporating the FSL for T1DM patients was associated with a marginal incremental cost for the public sector third-party payer and cost savings in Chile's private healthcare sector.
dc.description.funderAbbott Chile
dc.fuente.origenWOS
dc.identifier.doi10.1080/14737167.2023.2171989
dc.identifier.eissn1744-8379
dc.identifier.issn1473-7167
dc.identifier.urihttps://doi.org/10.1080/14737167.2023.2171989
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/92470
dc.identifier.wosidWOS:000924258700001
dc.issue.numero3
dc.language.isoen
dc.pagina.final363
dc.pagina.inicio353
dc.revistaExpert review of pharmacoeconomics & outcomes research
dc.rightsacceso restringido
dc.subjectBudget impact analysis
dc.subjectChile
dc.subjectcost analysis
dc.subjectdiabetes mellitus
dc.subjectflash glucose monitoring
dc.subjectself-monitoring of blood glucose
dc.subjectsevere hypoglycemic events
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleBudget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile
dc.typeartículo
dc.volumen23
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files